Taipei, Sept. 16 (CNA) Recall notices were issued by the Food and Drug Administration (FDA) on Friday for two brands of Japanese seirogan, a common antidiarrheal drug in Taiwan, informing people that 20 million pills produced in eight batches are to be recalled due to deviations from the drug's specifications.